New dry powder inhaler will improve delivery, says Aptar
Aptar Pharma has launched a new twistable dry powder inhaler (DPI) which it says is a “cost effective” way to improve drug delivery as well as patient compliance.
Archives for May 8, 2012
Indian minister rails against anti-generics smear campaign
The Indian government says multinational companies are running “a concerted campaign” against its generics industry.
FDA oversight driving closures of CMOs; Interphex speaker
Increased oversight by the FDA is causing some US-based CMOs to shut down, a speaker at Interphex said.
Effective controls still lacking for continuous processing says Interphex panel
Continuous processing is still hamstrung by a lack of control systems and is not ready for specific FDA guidance according to an industry expert panel which met at Interphex last week.
Know how your CMO will deliver its promises, says Baxter
“Understand not only what your CMO can do, but how they can get it done,” was Baxter’s message during a speech at the year’s Interphex in New York.
US biotech pursues Cetero for drug development delay costs
A US biotech is seeking $250,000 from Cetero to cover drug development delays caused by alleged breaches of contract.
BASF buys omega-3 maker Equateq citing pharma potential
BASF has bought omega-3 fatty acid maker Equateq, citing its pharmaceutical and dietary supplements businesses as key beneficiaries.